Capital raising when the share price is at close to 52 week lows.....does not sound like good news for existing shareholders (perhaps conditions in the US have not improved this quarter)
The only possible positive that I can think of is that StrongRoom AI seems to have gone into administration late last week, and they seem to be in a similar space (drug adherence), and StrongRoom seems to have had 20-30m in revenues (if I recall correctly)
Add to My Watchlist
What is My Watchlist?
